Comparing the current results to its competitors, Odyssey Health Inc reported Revenue increase in the 3 quarter 2026 by 0 % year on year. The revenue growth was below Odyssey Health Inc 's competitors' average revenue growth of 9.28 %, achieved in the same quarter.
Odyssey Health Inc 's Comment on Competition and Industry Peers
The competitive landscape includes rapid EKG devices that provide EKG readouts but do not offer digital heart mapping. Competitors include CardioResting (Nasiff), which provides a complete 12-lead PC-based cardiology system that is durable, reliable, easy to learn, and compatible with electronic medical records (EMR) with an unlimited database. Another competitor is Welch Allyn PC-Based Electrocardiograph, which automatically transfers patient information and test data into most EMRs to reduce redundant work and errors.
Actinium Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of targeted therapies for the treatment of various cancers.
Bionano Genomics Inc is a biotechnology company specializing in the development and commercialization of genomic analysis tools. Their business model revolves around offering proprietary genome imaging systems that provide high-resolution maps of DNA for researchers and clinicians to study genetic variations and diseases more effectively.
Co Diagnostics Inc is a biotech company that follows a business-to-business (B2B) model. They develop and manufacture molecular diagnostics for various infectious diseases. Their revenue is generated by selling these diagnostics directly to healthcare organizations, laboratories, and research institutions.
Cytodyn Inc is a biotechnology company that focuses on the development and commercialization of innovative treatments for a range of diseases, including cancer and viral infections. The company primarily generates revenue through the licensing and sale of its therapeutics to medical institutions and pharmaceutical companies. Cytodyn's business model revolves around the research and development of novel drugs, conducting clinical trials, and forming strategic partnerships to bring their innovative treatments to market.
DarioHealth Corp's business model revolves around providing digital health solutions to individuals with chronic diseases. Through their mobile health platform, they offer personalized tools and remote monitoring capabilities that empower patients to proactively manage their conditions. By combining software, data analytics, and medical devices, DarioHealth aims to enhance patient engagement, improve health outcomes, and reduce healthcare costs.
Sources:
Odyssey Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Odyssey Health Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
